Dentsply Sirona Inc (STU:DY2)
€ 18.4 -0.335 (-1.79%) Market Cap: 3.67 Bil Enterprise Value: 5.60 Bil PE Ratio: 0 PB Ratio: 1.55 GF Score: 61/100

DENTSPLY SIRONA Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 03:30PM GMT
Release Date Price: €34.08 (+1.19%)
Rachel Marie Vatnsdal Olson
JPMorgan Chase & Co, Research Division - Analyst

Perfect. Good morning, everyone. This is Rachel Vatnsdal with the Life Science Tools and Diagnostics team here at JPMorgan. Thanks so much for joining us today. I'm joined on stage by the Dentsply Sirona team. So as we typically do with these sessions, it will be 40 minutes, roughly 20 minutes of a presentation followed by 20 minutes of Q&A.

So if any of you in the room do have questions, feel free to either submit them via the portal or you can pin me it directly. And with that, I will pass it off to Simon.

Simon D. Campion
DENTSPLY SIRONA Inc. - CEO, President & Director

Good morning, everyone, and thank you, Rachel. One year into our transformation journey at Dentsply Sirona and following on the heels of our recent Investor Day, and we're pleased to be happy to provide you all an update today. On stage, I'm joined by Glenn Coleman, our Chief Financial Officer; Andreas Frank, our Chief Business Officer; and our Head of Investor Relations, Andrea Daley.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot